Recon: FDA advisors weigh OTC birth control pill; Gilead prevails in HIV drug patent suit

ReconReconBiologicsDiagnosticsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy